{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:12:42Z","timestamp":1758633162986},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T00:00:00Z","timestamp":1188950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Ophthalmol"],"published-print":{"date-parts":[[2007,10,10]]},"DOI":"10.1007\/s12009-007-0016-7","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T11:25:06Z","timestamp":1188905106000},"page":"163-165","source":"Crossref","is-referenced-by-count":3,"title":["Follicular Lymphoma Involving the Orbit"],"prefix":"10.1007","volume":"39","author":[{"given":"Yew Chong","family":"Yap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirit","family":"Ardeshna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Kosmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey E.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,5]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, et\u00a0al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265\u2013276","journal-title":"Blood"},{"key":"16_CR2","volume-title":"WHO classification of tumours. Pathology and genetics. Tumours of the haematopoietic and lymphoid tissues","year":"2001","unstructured":"Jaffe E. WHO classification of tumours. Pathology and genetics. Tumours of the haematopoietic and lymphoid tissues. IARC, Lyon; 2001"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ohc.2004.11.001","volume":"18","author":"DS Bardenstein","year":"2005","unstructured":"Bardenstein DS. Ocular adnexal lymphoma: classification, clinical disease, and molecular biology. Ophthalmol Clin North Am 2005;18:187\u2013197","journal-title":"Ophthalmol Clin North Am"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1007\/s00259-003-1157-6","volume":"30","author":"J Coffey","year":"2003","unstructured":"Coffey J, Hodgson DC, Gospodarowicz MK. Therapy of non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging 2003;30:S28\u2013S36","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","volume":"84","author":"C Jenkins","year":"2000","unstructured":"Jenkins C, Rose GE, Bunce C, et\u00a0al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 2000;84:907\u2013913","journal-title":"Br J Ophthalmol"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","volume":"17","author":"C Jenkins","year":"2003","unstructured":"Jenkins C, Rose GE, Bunce C, et\u00a0al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye 2003;17:809\u2013820","journal-title":"Eye"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","volume":"362","author":"KM Ardeshna","year":"2003","unstructured":"Ardeshna KM, Smith P, Norton A, et\u00a0al. Long term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced stage non Hodgkin\u2019s lymphoma: a randomised controlled trial. Lancet 2003;362:516\u2013522","journal-title":"Lancet"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/14656566.7.10.1273","volume":"7","author":"V Aurora","year":"2006","unstructured":"Aurora V, Winter JN. Follicular lymphoma: today\u2019s treatments and tomorrow\u2019s targets. Expert Opin Pharmacother 2006;7:1273\u20131290","journal-title":"Expert Opin Pharmacother"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"R Marcus","year":"2005","unstructured":"Marcus R, Imrie K, Belch A, et\u00a0al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005;105:1417\u20131423","journal-title":"Blood"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, et\u00a0al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005;106:3725\u20133732","journal-title":"Blood"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","volume":"102","author":"K Besien van","year":"2003","unstructured":"Van Besien K, Loberiza FR Jr, Bajorunaite R, et\u00a0al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003;102:3521\u20133529","journal-title":"Blood"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2004-03-1105","volume":"104","author":"E Morris","year":"2004","unstructured":"Morris E, Thomson K, Craddock C, et\u00a0al. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 2004;104:3865\u20133871","journal-title":"Blood"}],"container-title":["Annals of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12009-007-0016-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12009-007-0016-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12009-007-0016-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:14:12Z","timestamp":1559423652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12009-007-0016-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,5]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10,10]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s12009-007-0016-7","relation":{},"ISSN":["1530-4086","1558-9951"],"issn-type":[{"value":"1530-4086","type":"print"},{"value":"1558-9951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,5]]}}}